Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
Multi-targeted tyrosine kinase inhibitors as third-line regimen in advanced non-small cell lung cancer: a network meta-analysis. [electronic resource] by
- Zhang, Zhonghan
- Zhao, Yuanyuan
- Lu, Feiteng
- Hou, Xue
- Ma, Yuxiang
- Luo, Fan
- Zeng, Kangmei
- Zhao, Shen
- Zhang, Yaxiong
- Zhou, Ting
- Yang, Yunpeng
- Fang, Wenfeng
- Huang, Yan
- Zhang, Li
- Zhao, Hongyun
Publication details: Annals of translational medicine Sep 2019
In:
Annals of translational medicine vol. 7
Availability: No items available.
|
|
6.
|
Pemetrexed/carboplatin plus gefitinib as a first-line treatment for EGFR-mutant advanced nonsmall cell lung cancer: a Bayesian network meta-analysis. [electronic resource] by
- Zhang, Zhonghan
- Zeng, Kangmei
- Zhao, Shen
- Zhao, Yuanyuan
- Hou, Xue
- Luo, Fan
- Lu, Feiteng
- Zhang, Yaxiong
- Zhou, Ting
- Ma, Yuxiang
- Yang, Yunpeng
- Fang, Wenfeng
- Huang, Yan
- Zhang, Li
- Zhao, Hongyun
Publication details: Therapeutic advances in medical oncology 2019
In:
Therapeutic advances in medical oncology vol. 11
Availability: No items available.
|